8-K
NONE0001720580false00017205802022-03-182022-03-18

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 18, 2022

 

 

Adicet Bio, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38359

81-3305277

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

200 Clarendon Street

Floor 6

 

Boston, Massachusetts

 

02116

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 650 503-9095

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

ACET

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 1.01 Entry into a Material Definitive Agreement.

On March 18, 2022, Adicet Therapeutics, Inc. (“Adicet Therapeutics”), a wholly-owned subsidiary of Adicet Bio, Inc. (the “Company”) and CP Enterprises, Inc. d/b/a CP Construction (“CP Construction”) entered into Change Order No. 3 (the “Change Order No. 3”) to the Standard Form of Agreement between Owner and Contractor Where the Basis for Payment is a Stipulated Sum, effective as of April 2, 2021, by and between Adicet Therapeutics and CP Construction (the “Construction Agreement”), previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 9, 2021. The Construction Agreement provides for pre-construction and construction services at the Company’s office and laboratory space at 1000 Bridge Parkway, Redwood City, California 94065 (“1000 Bridge Parkway”) for consideration of approximately $14 million to CP Construction. The Change Order No. 3 increases the original approved budget for the construction by approximately $5 million in order to build one GMP cell processing and one vector manufacturing suite in addition to controlled materials warehousing at 1000 Bridge Parkway. Adicet Therapeutics and CP Construction previously entered into two prior change orders to the Construction Agreement, which increased the consideration payable to CP Construction by a nominal amount. As required under the Lease Agreement, dated as of October 31, 2018, by and between Adicet Therapeutics as Tenant, and Westport Office Park, LLC as Landlord, as amended, the Company has acquired the consent of the landlord for each change order to the Construction Agreement.


The Change Order Nos. 1, 2, and 3 to the Construction Agreement are filed as Exhibits 10.1, 10.2, and 10.3, respectively, to this Current Report on Form 8-K, and the description of the amendments are qualified in its entirety by reference to such respective exhibits.
 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

No.

Description

10.1

Change Order No. 1, dated September 23, 2021, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction.

10.2

Change Order No. 2, dated March 18, 2022, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction.

10.3

Change Order No. 3, dated March 18, 2022, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Adicet Bio, Inc.

 

 

 

 

Date:

March 24, 2022

By:

/s/ Nick Harvey

 

 

Name:

Title:

Nick Harvey
Chief Financial Officer

 


EX-10.1

Document G701

Change Order

 

 

 

 

Change Order Number: 01

 

 

Project: Adicet Therapeutics

1000 Bridge Parkway

Redwood City, CA 94065

 

Date: 21-Sep-21

 

Architect's Project No:

 

 

Owner

 

Architect

 

 

 

 

 

 

 

 

To Contractor: (Name and Address

CP Construction

a Division of CP Enterprises

Newark, CA 94560

 

Contract Date: 2 April 2021

Contract For: Tenant Improvements

 

 

Contractor

 

Field

 

Other

 

 

 

The Contract is changed as follows:

(Include, where applicable, any undisputed amount attributable to previously executed Construction Change Directives)

Pressurized Change

 

Per Western Allied and Adicet email dated 8/23/21 for the following work:

 

 

 

Demolition of Installed Duet

 

 

Upsizing (4) Evs

 

 

Upsize exhaust duct runs

 

 

Upsize supply duct run

 

 

Upsize (9) grilles

 

 

Subtotal

 

$ 124,000.00

10% Profit, Overhead & Insurance

 

$ 12,400.00

Total

 

$ 136,400.00

 


The original Contract Sum was

 

$ 13,625,700.00

The net change by previously authorized Change Orders

 

$ 0.00

The Contract Sum prior to this Change Order was

 

$ 13,625,700.00

The Contract Sum will be increased by this Change Order in the amount of

 

$ 136,400.00

The new Contract Sum including this Change Order will be

 

$ 13,762,100.00

The Contract will be unchanged by 0 days

 

 

The date of Substantial Completion as of the date of this Change Order therefore is

 

 

 


 

(Note: This Change Order does not include changes in the Contract Sum, Contract Time or Guaranteed Maximum Price which have been authorized by Construction Change Directive until the cost and time have been agreed upon by both the Owner and Contractor, in which case a Change Order is executed to supersede the Construction Change Directive.)

 

NOT VALID UNTIL SIGNED BY THE ARCHITECT, CONTRACTOR AND OWNER.

 

Form4 Architecture, Inc.

 

CP Construction

 

Adicet Therapeutics, Inc.

ARCHITECT (Firm Name)

 

CONTRACTOR (Firm Name)

 

OWNER (Firm Name)

 

 

 

 

 

120 2nd St# 2. San Francisco, CA 94105

 

6662 Mayhews Landing Rd. Newark, 94560

 

200 Constitution Dr. Menlo Park, CA 94025

Address

 

Address

 

Address

 

 

 

 

 

/s/ Paul Ferro

 

/s/ Leslie Hellewell

 

/s/ Charlie Penner

By (Signature)

 

By (Signature)

 

By (Signature)

 

 

 

 

 

Paul Ferro

 

Leslie Hellewell

 

Charlie Penner

Typed Name

 

Typed Name

 

Typed Name

 

 

 

 

 

September 23, 2021

 

September 21, 2021

 

September 22, 2021

Date

 

Date

 

Date

 

 

 

 

 

 

 


EX-10.2

Document G701

Change Order

 

 

 

 

Change Order Number: 02

 

 

Project: Adicet Therapeutics

1000 Bridge Parkway

Redwood City, CA 94065

 

Date: 7-Feb-22

 

Architect's Project No:

 

 

Owner

 

Architect

 

 

 

 

 

 

 

 

To Contractor: (Name and Address

CP Construction

a Division of CP Enterprises

Newark, CA 94560

 

Contract Date: 2 April 2021

Contract For: Tenant Improvements

 

 

Contractor

 

Field

 

Other

 

 

 

The Contract is changed as follows:

(Include, where applicable, any undisputed amount attributable to previously executed Construction Change Directives)

Vivarium Modifications

 

Per email correspondence with Charlie Penner on 2/3/22 for the following work:

 

 

 

Demo

 

$ 2,500.00

Electrical

 

$ 8,000.00

HVAC & Plumbing

 

$ 8,500.00

Fire Alarm

 

$ 2,000.00

Fire Sprinklers

 

$ 3,000.00

Frame & Drywall

 

$ 10,000.00

Tape & Paint

 

$ 4,500.00

Subtotal

 

$ 38,500.00

10% Profit, Overhead & Insurance

 

$ 3,850.00

Total

 

$ 42,350.00

 


The original Contract Sum was

 

$ 13,625,700.00

The net change by previously authorized Change Orders

 

$ 136,400.00

The Contract Sum prior to this Change Order was

 

$ 13,762,100.00

The Contract Sum will be increased by this Change Order in the amount of

 

$ 42,350.00

The new Contract Sum including this Change Order will be

 

$ 13,804,450.00

The Contract will be increased by 30 days

 

 

The date of Substantial Completion as of the date of this Change Order therefore is

 

 

 


 

(Note: This Change Order does not include changes in the Contract Sum, Contract Time or Guaranteed Maximum Price which have been authorized by Construction Change Directive until the cost and time have been agreed upon by both the Owner and Contractor, in which case a Change Order is executed to supersede the Construction Change Directive.)

 

NOT VALID UNTIL SIGNED BY THE ARCHITECT, CONTRACTOR AND OWNER.

 

Form4 Architecture, Inc.

 

CP Construction

 

Adicet Therapeutics, Inc.

ARCHITECT (Firm Name)

 

CONTRACTOR (Firm Name)

 

OWNER (Firm Name)

 

 

 

 

 

120 2nd St# 2. San Francisco, CA 94105

 

6662 Mayhews Landing Rd. Newark, 94560

 

200 Constitution Dr. Menlo Park, CA 94025

Address

 

Address

 

Address

 

 

 

 

 

/s/ Paul Ferro

 

/s/ Leslie Hellewell

 

/s/ Chen Schor

By (Signature)

 

By (Signature)

 

By (Signature)

 

 

 

 

 

Paul Ferro

 

Leslie Hellewell

 

Chen Schor

Typed Name

 

Typed Name

 

Typed Name

 

 

 

 

 

March 2, 2022

 

February 7, 2022

 

March 18, 2022

Date

 

Date

 

Date

 

 

 

 

 

 

 


EX-10.3

ocument G701

Change Order

 

 

 

 

Change Order Number: 03

 

 

Project: Adicet Therapeutics

1000 Bridge Parkway

Redwood City, CA 94065

 

 

 

Architect's Project No:

 

 

Owner

 

Architect

 

 

 

 

 

 

 

 

To Contractor: (Name and Address

CP Construction

a Division of CP Enterprises

Newark, CA 94560

 

 

Contract For: Tenant Improvements

 

 

Contractor

 

Field

 

Other

 

 

 

The Contract is changed as follows:

(Include, where applicable, any undisputed amount attributable to previously executed Construction Change Directives)

Pressurized Change

 

Adicet GxP Lab Rev 01 (Per Pricing Revision 02 set & the 1/20/22 Preliminary

 

Schedule)

 

 

 

Demo

 

$ 165,000.00

Demo existing finishes & reinstall

 

$ 350,000.00

Walls

 

$ 248,815.00

VCT and carpet flooring

 

$ 9,000.00

HVAC

 

$ 1,662,201.00

Electrical

 

$ 567,000.00

Plumbing

 

$ 499,644.00

Fire Sprinklers

 

$ 61,237.00

Fire alarms

 

$ 47,950.00

Doors

 

$ 151,300.00

Lab casework, tables and lockers

 

$ 134,250.00

Flooring labs

 

$ 134,700.00

Equipment lift

 

$ 130,000.00

Roofing

 

$ 45,000.00

Structural steel

 

$ 275,000.00

T-bar ceilings

 

$ 130,320.00

FRP walls

 

$ 75,000.00

Painting

 

$ 61,580.00

Final Janitorial

 

$ 7,000.00

General conditions & PM

 

$ 90,000.00

Subtotal

 

$ 485,017.00

10% Profit, Overhead & Insurance

 

$ 484,501.70

Total

 

$ 5,329,518.70

 


The original Contract Sum was

 

$ 13,625,700.00

The net change by previously authorized Change Orders

 

$ 178,750.00

The Contract Sum prior to this Change Order was

 

$ 13,804,450.00

The Contract Sum will be increased by this Change Order in the amount of

 

$ 5,329,518.70

The new Contract Sum including this Change Order will be

 

$ 19,133,968.70

The Contract will be increased by see attached schedule ( ) days

 

 

The date of Substantial Completion as of the date of this Change Order therefore is

 

 

 


 

(Note: This Change Order does not include changes in the Contract Sum, Contract Time or Guaranteed Maximum Price which have been authorized by Construction Change Directive until the cost and time have been agreed upon by both the Owner and Contractor, in which case a Change Order is executed to supersede the Construction Change Directive.)

 

NOT VALID UNTIL SIGNED BY THE ARCHITECT, CONTRACTOR AND OWNER.

 

Form4 Architecture, Inc.

 

CP Construction

 

Adicet Therapeutics, Inc.

ARCHITECT (Firm Name)

 

CONTRACTOR (Firm Name)

 

OWNER (Firm Name)

 

 

 

 

 

120 2nd St# 2. San Francisco, CA 94105

 

6662 Mayhews Landing Rd. Newark, 94560

 

200 Constitution Dr. Menlo Park, CA 94025

Address

 

Address

 

Address

 

 

 

 

 

/s/ Paul Ferro

 

/s/ Leslie Hellewell

 

/s/ Charlie Penner

By (Signature)

 

By (Signature)

 

By (Signature)

 

 

 

 

 

Paul Ferro

 

Leslie Hellewell

 

Charlie Penner

Typed Name

 

Typed Name

 

Typed Name

 

 

 

 

 

March 11, 2022

 

March 18, 2022

 

March 18, 2022

Date

 

Date

 

Date